Categories

Above the Fold

PHARMA: A bizzaro world view on reimportation

Roger Pilon from Cato, the thinking man’s libertarian think-tank (as opposed to AEI or Heritage) last week, decided that the US should give up on the reimportation ban. The basic reasoning is that it won’t be a big deal as the drug companies won’t let too much inventory go overseas, and if we let importation happen, the American market will force price rises abroad.video of this debate between Cato’s Pilon in favor of reimportation and an AEI staffer Jack Calfee who opposes it. Almost a doppler world here in which the AEI scholar is arguing that price controls are OK in poor countries because they keep drugs available in poor countries. Reimportation would, according to both of these "free-marketers", see higher prices abroad. They are of course both opposed to price controls here–such as happen abroad. But what that means in real life is monopsony purchasing by the government. That could happen here very easily by CMS, the VA and the states agreeing to negotiate with the drug companies, as the VA does and Medicaid sort of does. This type of "price control," PhRMA tells us all the time, would ensure that R&D for pharma would collapse, and we’d all be dying in the streets. Both Pilon and his AEI counterpart note that as government’s share of the drug market increases, these "price negotiations" are likely to happen anyway.

You can see a long

No one mentions the obvious question which is, in which industry would people invest their money if margins in pharma went down slightly? Seems to me that a blockbuster is a blockbuster and will find investment capital whether it’s returning 30% or 20% net margins. Of course that would mean that reductions in costs at pharma companies would have to happen somewhere, and the obvious answers are from the two biggest slices of the revenue pie at pharma companies–those being sales & marketing and profits. (R&D is the third biggest number). It’s also worth noting that many industries such as high-tech and autos spend large amounts on R&D without either patent protections or such high margins. And yet they manage to bring out new products all the time at continually lower prices.

QUALITY: Millenson demands a shock to the system

Writing an Op-Ed in USA Today, Michael Millenson says that making a national error reporting system voluntary won’t work. The Senate voted 98-0 to create such a system last week and USA Today had an editorial saying that it was a good idea, but should have gone further. In some ways that such articles appear in the mainstream press shows the great progress since the IOM issued the To Err is Human report, given organized medicine’s ability over the previous century to quiet the incipient debate on the medical error and quality topic, (as detailed by Millenson in the wonderful Demanding Medical Excellence). But the IOM set out a goal of a reduction in errors of 50% in five years. Well the report was issued 5 years ago next month and no one is pretending that target has been reached (outside of LDS hospital in Salt Lake City, scroll down here to the June 10 entry for more on that)Here’s what Millenson said yesterday:

While voluntarism is valuable, it has been five years since a landmark IOM report made patient safety a public scandal. During that time, doctors and hospitals have not voluntarily organized to stop the preventable deaths and injuries of hundreds of thousands of patients with anything close to the energy used to battle malpractice awards worth hundreds of thousands of dollars.

Doctors and hospital managers are not venal and uncaring. In fact, many care so much that they find it too painful to face up to the commonplace nature of errors. As a result, doctors routinely protest that the patient-safety issue is overblown. I’ve seen it firsthand hundreds of times. If you really believe in systemic change, you have to be willing to shock a lethargic system into abandoning the status quo.

The way to do that is with the mandatory reporting of serious errors. In Minnesota, for example, progressive hospitals supported the mandatory reporting and analysis of 27 serious events, along with appropriate confidentiality and legal ”safe harbor” provisions. Moreover, errors are tabulated and made public each year. Across the U.S., a few courageous hospitals even involve patient representatives in error-prevention panels.

No member of Congress would think of making airline-crash prevention voluntary. Protecting the sick and the vulnerable among us is surely at least as important.

PBMs: Spitzer puts the boot into Express Scripts

NY A-G Eliot Spitzer continues his swath through the boardrooms of America. He’s piling in on the recent investigations and he comes right out and accuses Express Scripts of fraud.

The suit alleges the company inflated the cost of generic drugs at the expense of New York state’s largest employee health plan, the Empire Plan. It charges the company cheated the state on payments from drug companies that Express Scripts received when negotiating on behalf of New York. Spitzer, who has been probing the company for a year, said the abuses occurred over a five-year period and cost the state $100 million. Also named as defendants were two subsidiaries of Cigna Corp.

“They are using their role as an intermediary to line their own pockets,” he told reporters on a conference call. “They were simply committing fraud, and it cuts to the core of the integrity of the company.” Spitzer said abusive practices are not limited to Express Scripts but are rampant throughout the sector. Pharmacy benefits managers, or PBMs, are brokers that act as middlemen, buying drugs for employers and health plans.

That’s not exactly soft speaking, and it doesn’t augur well for PBMs if they have to administer a Medicare program in 2006 that is being run by a Democratic HHS, with possibly a Justice department overseen by an Attorney-General called Spitzer.

POLICY: HSC confirms that employer-based insurance fell during recession

Given the disarray in the individual insurance market, the latest survey from the Center for Health System Change (here’s the News Release and here’s the longer issue brief) proves that economics is alive and well. There is such a thing as an income effect and a price effect–so if business income/revenue goes down and the price of insurance goes up, well funnily enough a lot less people are going to be getting health insurance from their employers. And somewhere mixed in that is the little nugget that if you don’t have a job any more, as we used to say in England, you have two chances of having an employer provide you with health insurance: No chance and (As this is a family blog. I’ll censor the rest of this remark).girlie-men or no girlie-men, and the other is more people on both sides of the patient-provider relationship discovering how inadequate Medicaid is. Furthermore most of the increase was for children rather than adults, so there was some relative shift in who within families got insurance, but even so public sector insurance rolls expanded for adults too.The Blogging of the President which explains (to my satisfaction at least) where this all will drift to: The reason that eventually we’ll get to some kind of compulsory national health care system is grounded in the fact that for the last hundred years if you (or your employer, or the government if like the elderly you had some power and could force the burden onto other taxpayers ) could not afford insurance, you went without. That meant that the medical system could keep charging as much as it liked because those who couldn’t afford it would be dumped into the safety valve known as uninsurance. In such a system two things eventually will happen.

The number of those with employer-provided insurance fell from 67% in 2001 to 63% in 2003. That fast a fall in that short a space of time is pretty significant, and of course starts to throw many more people into the individual insurance market and/or into uninsurance, which are pretty closely related if you’re sick anyway. This also confirms why health insurance is becoming a bigger and bigger deal on the campaign trail as more people are now more aware that growth in health insurance premiums actually costs them something directly (rather than depresses their incomes indirectly as it has for decades now).

The other thing that has been going on is another expansion of Medicaid, which almost mirrors the huge expansion of Medicaid during the early 1990s recession. The number of people getting insurance from public sources went up by 3%. However, that in turn means two things. One is massive pressure on state budgets,

But the big overall message is that we are moving whether we like it or not into a system where the combination of government programs (including Medicare of course) and individual insurance will eventually overtake the employer-based group insurance that has been the mainstay of the US health insurance "system" (and I use that word very loosely). How fast that transition happens depends somewhat on politics, but eventually those with good health benefits at work will be in the minority.

All of this will increase the eventual pressure that we’ll face as a nation to get to grips with this. In fact I’m going to repeat a para here that I wrote in the comments over at

First, costs which have been allowed to grow without any controls will eventually become too great for those paying the bills (esp. large employers). They will continue to push people out into un or under-insurance, which is exactly what the HSC study is finding.

Second, the number of un or under-insured will become so great and politically powerful, that it will end up creating a compulsory "national insurance" system. That system will shift the burden from employers to the taxpayer, which will coincidentally make the employers happy (and most people too, if international surveys are to be believed..)

And once everyone’s in the system and there’s a direct correlation between taxes and health spending, healthcare spending will come under much tighter control. After all we’re Americans and we hate taxes (so long as levied by government rather than the health care system which calls them premiums).

This happened in the rest of the world between 1945 and 1970. It nearly happened in America in 1993, and it will happen sometime in the next 20-40 years here. This isn’t an ideological argument, it just has to play out that way unless health care costs go downwards over that time, and I hasten to guess that not even Mark (Note: Mark was a previous poster in this thread who hated Canadians and poor people) thinks that will happen.

POLICY/POLITICS: Kerry’s post-convention bounce

Jones the Policy Wonk sends me these post-Convention polling numbers.

Internals from ABC poll post-convention–Kerry went from 3% ahead on healthcare to 19% ahead. (Sorry I can’t figure out an easy way to present this!)

The numbers in order are "Now" then " Pre-convention" then "Net Change" (or bounce)Trust Candidate on These Areas:Health careKerry +19 Kerry +3 Kerry +16TerrorismBush +3 Bush +18 Kerry +15IraqKerry +2 Bush +12 Kerry +14TaxesKerry +6 Bush +6 Kerry +12EducationKerry +13 Kerry +1 Kerry +12EconomyKerry +11 Bush +1 Kerry +12Health careKerry +19 Kerry +3 Kerry +16Int’l relationsKerry +9 NA NAIntelligenceKerry +5 NA NA

So the post convention bounce has the Dems massively up in their domestic strengths and even up on Iraq, Foreign relations and Intelligence. "Terrorism" remains Bush’s sole refuge and amazingly enough we get another terror warning just 2 days after the convention.

It’s hard to divine who’s going to win this thing, and it speaks volumes to the strength of the Republicans corporate/Christian right base that they’re even in the race given the state of the economy. But THCB readers should probably start imagining the possibility of a weaker than Clinton-like Democratic White House and maybe even a narrow majority in the Senate. I’ll be blogging more about that in weeks to come.

Massively off topic–I know that people don’t want to criticize the C-in-C about terrorism and I don’t hold him responsible for 9-11 but surely someone somewhere in the administration or intelligence services should be accountable for the fact that before 2001 Al-Quaeda was easily infiltrated by at least one white American and one white Australian. Yet the CIA and its sister orgs didn’t even bother to try, and we never knew what was coming.

HEALTH PLANS/POLICY: More information on the individual insurance market, and yes it still sucks!

The Kaiser Family Foundation does a great job in putting health issues out there in an objective matter. Unfortunately their latest effort on the individual insurance market is, in their own terms, an attempt to get out information without implications. And this is a place in which the implications are clear but politically unpalatable.What does the report say? Basically insurers in the individual market sell policies with higher deductibles and lower premiums compared to those in the group market. Of course the individual market place has higher underwriting and administration costs (and distribution fees–think brokers). I’ve recently helped 2 (college educated & female) people understand their quotes and options in recent weeks. Basically you’re better off buying the cheapest plan with the high deductible because there’s a very close to 1 to 1 correlation between adding premium to reduce deductibles/max out-of-pockets, and of course if you stay healthy you may not ahve to pay those out-of-pocket costs. In addition in any one series of quotes for an individual the range of premiums versus benefits versus deductibles and out-of-pocket costs is bewildering–which results in many of my friends asking me to figure it out for them.

How is this study being reported? Modern Healthcare pulled this lead sentence out of the report for their Daily Dose newsletter "Group health insurance for an individual was nearly twice as costly as individual coverage bought on the market" That’s true as far as it goes, but you actually have to watch the video and dive into the report before you figure out that, dollar for dollar spent on premiums, benefits in the individual market are worse than in the group market.The panel which included a KFF staffer, the CEO of eHealthinsurance and a California Blue Shield exec also distinguished between short term and long term policies. One stated difference between short-term and long term is that short-term ones are not renewable. The other issue not raised by the panel was that short-term policies are not individually underwritten….once you get past the few questions on the short-term form declaring you don’t have some dread disease, you’re in. Conseuqntly many people spend years stringing together short-term polcies from different companies. However most long-term individual policies are underwritten by the insurer which looks at your recent medical history, which of course may include several not quite so dread diseases/episodes which might still bump up your premiums drmatically.One audience question resulted in the answer that if an insurer cannot deny coverage to "sick people" it doubles the premium. The defensive answer from the panel was that it’s only bad in states where they have community rating (e.g New York), but that’s actually rubbish. I applied via eHealthinsurance for a Blue Shield policy in California (which couldn’t be more in this report’s wheelhouse given that those are the two companies taking part) in 2003. I was quoted $60 a month for a high deductible plan but when they found I’d had surgery the year before the exact same policy went to $300 a month.However, eventually Gary Claxton from KFF said the key point. In 90% of states sick people can be be excluded. Either insurers are not writing them insurance or charging them way way too much. In other words health insurance in the individual market isn’t available for many if not most of the people who actually need it. I’m a good example of this as I’ve been forced to find a trade association group to join via which I could join a buying group (PacAdvantage) so I can buy an expensive but not outrageous plan. Of course if I get healthier and can get away with a cheaper individual plan, I’ll leave the group and contribute to its own insurance death spiral.So depsite all the nice words, the individual insurance market continues to suck. That’s essentially the same conclusion that noted commie Mark Pauly came to in Health Affairs a couple of years back. Well he actually said that 80% of consumers in the individual market do OK, while 20% find it doesn’t work for them. As it stands the market is unreformable. Saying that it’s 80% OK is a little like saying that 80% of Iraq is OK because it’s not actually blowing up right this minute, and the situation there is all fine and dandy. But why would we want to just focus on the bad news?

POLICY: The Industry Veteran on negative advertising, the ethics of clinicians, and is THCB more boring than the Democratic Convention?

The Industry Veteran is back and on fine form, picking up the ball on a piece of crossed out editorial about my least favorite American politician, and running it into the realms of whether the Democrats are right (as Jones the Policy Wonk suspects) to take the milquetoast route, and whether marketing to doctors needs to be different than to other clinicians.

"Theocratic fascist?" I love it. Now those are the terms and the tone I expect to see on a blog. If I wanted neuterizing, backpedalling, vague ambiguity and maudlin sentiment ("hope," "we can do better," "a government as good as its people") I’d watch the Democratic convention.

This leads directly to my opening rant. The Democrats apparently believe that aggressive Bush bashing will repel the "persuadable" 20% of the electorate and, for that reason, most of their carefully orchiectomized speeches have been as energizing as 20mg of Valium. Two reasons make me think they’re making a bad mistake.

Let me start by recalling two, well established facts of voting behavior in this country: (1) voting participation varies directly with socio-economic status and; (2) only half of eligible voters go to the polls. This means that non-voting prevails among the lower two-thirds of the economic ladder that constitutes the Democrats’ social base. Election victories by Democrats, therefore, owe more to mobilizing voting among this base than to persuading the half-assed/undecideds. Democratic non-voters need a reason or reasons to vote. Platitudes about a shining city on a hill, restoring opportunity to America or giving us security with peace don’t cut it. A candidate who lacks personal magnetism, together with the lachrymose sentimentality that Democrats have been shoveling out all week, produce responses ranging from indifference to cynicism and distrust, none of which provides lapsed Democrats with an incentive to vote.

My second argument for sharper, more abusive language contradicts the pollsters’ assertion that negative campaigning and personal attacks merely turn off voters. Pharmaceutical research that I have conducted over many years with physicians and consumers leads me to suspect that the Democrats are receiving some bad advice. When asked how they feel about ads and other promotions that slam a competitor’s product, physicians and consumers typically give the socially correct response by saying that they disdain it. Further probing beneath this response indicates a different, more complicated process at work. Both physicians and laymen disparage negative or critical promotions that lack specificity because the course of action suggested by such communication (i.e., buy our product rather than the competitor’s) does not follow logically. As a result, test audiences believe that promotions full of "empty abuse" insult their intelligence. Physicians, for example, want to see the results of published studies, together with tables, charts and a condensed version of the supporting data. Consumers seek their own forms of corroborating evidence, and this varies according to the product, the market segment and several other factors. Given a rationale that effectively informs their selection process, physicians and consumers actually welcome a sharply stated conclusion: the other guy’s product is less effective and more poorly tolerated than ours. In short, go ahead and call John Ashcroft a theocratic fascist after first discussing the draconian features of the Patriot Act. Call George Bush an arrogant dope, a plutocrat and a lying scumbag after first discussing, well, any of his policies. Hey, if a longtime Republican operative such as David Gergen thinks the Democrats wasted a big opportunity by going soft on Bush, I think he may know something.

Second rant. I mentioned in a previous posting that I completed a study earlier this year involving the policies and practices of Big Pharma companies relative to the OIG/PhRMA guidelines for promoting to healthcare professionals. (OIG is the Office of the Inspector General at the Department of Health and Human Services; PhRMA is the Pharmaceutical Research and Manufacturers Association, Big Pharma’s trade lobby.) In response to exposes over the past few years that featured "dine-n-dash" and paid vacations in Aruba, these two organizations each issued guidelines to specify acceptable and prohibited practices for pharmaceutical companies promoting their products to physicians and other professionals. We first assessed the policies and monitoring processes used by the largest pharmaceutical companies for assuring compliance with these guidelines. Then we analyzed their actual promotional practices out in the field. Suffice it to say that while the overall level of bribery and bribery-in-kind has diminished slightly or has become less overt, the levels of compliance vary among the companies and nearly all reflect major disparities between policy and practice.

More recently a client asked us to make a similar assessment among diagnostic device companies. We found that while compliance differences also exist among these competitors, such differences are smaller than among the pharma companies and, more importantly, the general level of bribery and bribery-in-kind is also far lower. This reduced level of baksheesh became evident early in the study, so we spent a good deal of time and effort trying to account for it. While any complex social behavior usually results from multiple factors, there is a principal reason why fewer payoffs, involving lesser amounts, occur in the diagnostics business. Stripped to its essentials, the promotion of diagnostics involves a far smaller number and proportion of office-based physicians who would demand such gratuities. Very often the decision-makers who select/recommend diagnostic products are clinical chemists, diabetes nurse educators, microbiologists and other non-physicians. Some decision-makers are purchasing agents for hospital and other buying groups. Their product selections must provide strict cost justifications that leave little room for the subjective preferences subject to gratuities. Once again, our princes with stethoscopes, these Mafiosi doctori and purveyors of the Hippocratic myth, have dipped their beaks into the underground economy of healthcare to raise the costs and lower the ethical standards.

BLOGS/INTERVIEW: Interview with yours truly at Managed Care magazine

So in the every wierder world where bloggers looking at media are looked at by media too, I’m now joining in. There’s an interview with me in the latest issue of Managed Care magazine. You can read it, titled Matthew Holt: Internet Pundit Thrives on the Biggest Issues online, but if you get the hard copy of the magazine you see the lovely photos of me too! And if you got here via Managed Care magazine, welcome and hello!

assetto corsa mods